News & Perspective

Mar 16, 2017

Mar 16, 2017
NIH researcher

Trump's budget cuts 20% of NIH; groups express outrage

The budget supports earlier commitment to Gavi vaccine initiatives but dials back funds for other global health efforts.

Oct 01, 2013

Oct 01, 2013
US Capitol building

Fed shutdown affects disease detection, food safety

Response to seasonal flu, H7N9, MERS, and other threats could be markedly diminished.

Dec 26, 2012

Dec 26, 2012

Experts differ on HHS select-agent proposal for H5N1

(CIDRAP News) – Some professional groups and scientists think it's a good idea to classify highly pathogenic avian (HPAI) H5N1 influenza viruses as "select agents" requiring special research precautions, while others say the step is unnecessary and would impede research, according to comments they have filed with the US Department of Health and Human Services (HHS).

Apr 07, 2011

Apr 07, 2011

IDSA calls for broad attack on antimicrobial resistance

(CIDRAP News) – Warning that medical procedures such as surgery and chemotherapy will become impossible if current trends continue, the Infectious Diseases Society of America (IDSA) today called for a many-pronged campaign to counter the ever-growing threat of antimicrobial resistance.

Jan 28, 2011

Jan 28, 2011

Experts air kinks in antiviral use during H1N1 pandemic

(CIDRAP News) – Although antiviral drugs were used to treat many seriously sick people during the H1N1 influenza pandemic, experts at a conference today said they could have been used more widely and that some opportunities to learn from their use were missed.

Jun 23, 2010

Jun 23, 2010

As EUAs expire, HHS says pandemic emergency is over

(CIDRAP News) – Federal officials today allowed the public health emergency declaration that was prompted by the H1N1 influenza outbreak last year to lapse, signaling an end to emergency authorizations for certain special uses of antiviral drugs and other items.

Oct 29, 2009

Oct 29, 2009

Statins may help patients with severe seasonal flu

(CIDRAP News) – Commonly available drugs that are sold in lower-cost generic versions improve the survival of patients hospitalized for seasonal influenza, researchers reported today, raising the possibility of a widely available treatment that could be used in a severe flu pandemic if other drugs are in short supply.

Oct 26, 2009

Oct 26, 2009

Emergency authorization for peramivir draws fast response

(CIDRAP News) – Requests to use the intravenous (IV) antiviral drug peramivir in hospitalized H1N1 flu patients came quickly after the government issued an emergency use authorization (EUA) Oct 23, a Centers for Disease Control and Prevention (CDC) official said today.

Pages

Sort Results By:

 Sort Results By:

Narrow results by:

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation 3MAccelerate DiagnosticsGilead 
Grant support for ASP provided by

  Become an underwriter»